13880-05-2 | N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$24.00	$17.00
5g	97%	in stock	$33.00	$23.00
25g	97%	in stock	$119.00	$84.00
100g	97%	in stock	$383.00	$268.00

Description

• Catalog Number: AA58888
• Chemical Name: N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide
• CAS Number: 13880-05-2
• Molecular Formula: C7H13NO4
• Molecular Weight: 175.1824
• MDL Number: MFCD00081045
• SMILES: OCC(NC(=O)C=C)(CO)CO

Computed Properties

• Complexity: 157
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 5
• XLogP3: -2

Upstream Synthesis Route

N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide is a versatile compound widely used in chemical synthesis as a key building block for the development of various advanced materials. Its unique molecular structure enables it to participate in a range of chemical reactions, making it invaluable for the creation of complex organic compounds. In particular, this compound is known for its application in the synthesis of polymers, resins, and specialty chemicals. Its hydroxyl and amide functional groups provide opportunities for functionalization and modification, allowing for fine-tuning of properties such as solubility, reactivity, and stability. Furthermore, N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide plays a crucial role in the creation of bioconjugates and pharmaceutical intermediates, showcasing its significance in the field of medicinal chemistry and drug development. This compound's versatility and reactivity make it a valuable asset in the toolkit of synthetic chemists seeking to push the boundaries of innovation in the realm of chemical synthesis.

Literature

• Influence of denaturants on native-state structural fluctuations in azurin probed by molecular size-dependent quenching of Trp phosphorescence.

  The journal of physical chemistry. B 20111124

• Grafting of silica with a hydrophilic triol acrylamide polymer via surface-initiated 'grafting from' method for hydrophilic-interaction chromatography.

  Journal of separation science 20111101

• Design considerations in the use of interdigitated microsensor electrode arrays (IMEs) for impedimetric characterization of biomimetic hydrogels.

  Biomedical microdevices 20110401

• Amplitude spectrum of structural fluctuations in proteins from the internal diffusion of solutes of increasing molecular size: a Trp phosphorescence quenching study.

  Biochemistry 20110215

• The effect of temperature on the impedimetric response of bioreceptor hosting hydrogels.

  Biosensors & bioelectronics 20110115

• Characterization of electroconductive blends of poly(HEMA-co-PEGMA-co-HMMA-co-SPMA) and poly(Py-co-PyBA).

  Biomacromolecules 20090914

• Trehalose enhanced the freezability of Poodle dog sperm collected by an artificial vagina (AV).

  Animal reproduction science 20071101

• New tensio-active molecules stabilize a human G protein-coupled receptor in solution.

  FEBS letters 20070515

• Controlling the association of adamantyl-substituted poly{N-[tris(hydroxymethyl)methyl]acrylamide} and a beta-cyclodextrin/epichlorohydrin polymer by a small drug molecule--naproxen.

  Chemistry & biodiversity 20070101

• Tris(hydroxymethyl)aminomethane induces conformational change and crystal-packing contraction of porcine pancreatic elastase.

  Acta crystallographica. Section F, Structural biology and crystallization communications 20060701

• Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres.

  Journal of vascular and interventional radiology : JVIR 20040201

• In vitro and in vivo evaluations of THAM derived telomers bearing RGD and Ara-C for tumour neovasculature targeting.

  European journal of medicinal chemistry 20030901

• In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents.

  Journal of vascular and interventional radiology : JVIR 20030501

• Complement activation by substituted polyacrylamide hydrogels for embolisation and implantation.

  Biomaterials 20020601